In cisplatin-resistant ovarian cancer cells, m7G modification significantly enhances translation of EGFR pathway genes and activates PI3K/AKT/mTOR signaling, which reduces apoptosis sensitivity (47). Here, AKT1 is linked to ovarian carcinoma.